The Hindu·3 min read·medium

CitiusTech Appoints Dhaval Shah as Acting CEO and Shyam Karunakaran as President to Lead Next Phase of Growth and Transformation

C
cuelive
CitiusTech Appoints Dhaval Shah as Acting CEO and Shyam Karunakaran as President to Lead Next Phase of Growth and Transformation
AI Summary

CitiusTech has appointed Dhaval Shah as Acting CEO and Shyam Karunakaran as President following the departure of Rajan Kohli. The leadership transition aims to guide the company through its next phase of growth in healthcare AI and digital transformation.

MUMBAI, India , Aug. 17, 2026 /PRNewswire/ -- CitiusTech , a leading digital and enterprise AI company for healthcare and life sciences organizations, today announced that Dhaval Shah, Chief Business Officer for the MedTech (HMT) and Life Sciences (HLS) markets, has been elevated to the role of Acting Chief Executive Officer, effective immediately. Shyam Karunakaran, Chief Business Officer for Healthcare Payer & Platforms (HHP & Platforms), has been elevated to the role of President, with broad responsibilities spanning enterprise strategy, markets, growth, and execution. Rajan Kohli, Chief Executive Officer, has decided to move on from his role by the end of August 2026 to pursue other opportunities.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
businesstechnologyhealth

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in